Thanks for your post Enumerate.
You wrote;
I am not 100% sure, but I think the diagnostic testing technology falls under the FDA Medical Devices regime. This is much lighter weight than full drug development. This means that Phylogica could take this to the market directly (and at a reduced cost and time).
I believe so too. It's a device so would have low regulatory hurdles.
Regards,
Tony
Thanks for your post Enumerate.You wrote;I am not 100% sure, but...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 18.8¢ | $963.9K | 4.978M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2692 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 445208 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |